The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 135-138

  Gremmel, Thomas ^a   Kopp, Christoph W ^a   Steiner, Sabine ^a   Seidinger, Daniela ^a   Ay, Cihan ^a   Koppensteiner, Renate ^a   Mannhalter, Christine ^a   Panzer, Simon ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

P selectin; P2Y12 ADP receptor reactivity; Pro715 allele

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; P SELECTIN GLYCOPROTEIN LIGAND 1; PROLINE; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR; SELECTIN; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; AGED; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL ARTERY STENOSIS; PLATELET REACTIVITY INDEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; STENT; THROMBOCYTE ACTIVATION;

ADULT; ALLELES; ANGIOPLASTY; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; POLYMORPHISM, GENETIC; PROLINE; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; TICLOPIDINE;

EID: 79960262472     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.029     Document Type: Article

References (17)

1. Kee F., Morrison C., Evans A.E., et al. Polymorphisms of the P-selectin gene and risk of myocardial infarction in men and women in the ECTIM extension study. Etude cas-temoin de l'infarctus myocarde. Heart 2000, 84:548-552.
2. Tregouet D.A., Barbaux S., Poirier O., et al. SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease. Ann Hum Genet 2003, 67:504-511.
3. Andre P., Hartwell D., Hrachovinova I., Saffaripour S., Wagner D.D. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000, 97:13835-13840.
4. Ay C., Jungbauer L.V., Sailer T., et al. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 2007, 53:1235-1243.
5. Ridker P.M., Buring J.E., Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001, 103:491-495.
6. Bonello L., Paganelli F., Arpin-Bornet M., et al. Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 2007, 5:1630-1636.
7. Angiolillo D.J., Bernardo E., Capodanno D., et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 2010, 55:1139-1146.
8. Marschang P., Friedrich G.J., Ditlbacher H., et al. Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol 2006, 106:183-190.
9. Ikeda H., Takajo Y., Ichiki K., et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995, 92:1693-1696.
10. Blann A.D., Lip G.Y., Beevers D.G., McCollum C.N. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997, 77:1077-1080.
11. Lee D.S., Larson M.G., Lunetta K.L., et al. Clinical and genetic correlates of soluble P-selectin in the community. J Thromb Haemost 2008, 6:20-31.
12. Rinaldi M.J., Kirtane A.J., Piana R.N., et al. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Am Heart J 2008, 155:654-660.
13. Cambien B., Wagner D.D. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med 2004, 10:179-186.
14. Vandendries E.R., Furie B.C., Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004, 92:459-466.
15. del Conde I., Nabi F., Tonda R., et al. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol 2005, 25:1065-1070.
16. Blann A.D., Tan K.T., Tayebjee M.H., et al. Soluble CD40L in peripheral artery disease Relationship with disease severity, platelet markers and the effects of angioplasty. Thromb Haemost 2005, 93:578-583.
17. Seyfarth H.J., Koksch M., Roethig G., et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Am Heart J 2002, 143:118-123.